Nilotinib in KIT-driven Advanced Melanoma: Results from the Phase II Single-Arm NICAM Trial.
CELL REPORTS MEDICINE(2024)
Key words
KIT mutation,tyrosine kinase inhibitor,melanoma,mucosal,acral,liquid biopsy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined